4 July 2024
Takeda Oncology HCP professional development programme
There are fifteen places available for health care professionals in haemato-oncology, colorectal cancer or lung cancer, on this innovative non-promotional, educational programme that aims to support HCPs in enhancing their contribution to patient care and the healthcare system and in building their leadership skills. The programme runs over approximately a year. It includes completion of seven soft skills e-learning modules, attendance at one two-day face-to-face workshop, use of a 360o appraisal tool and an opportunity to receive individual coaching support.
100% of cohort 1 attendees who took part in the programme in 2022 said it was very likely they would recommend this programme to a colleague.
Testimonials from Cohort 1:
‘I found all of it so useful but loved the strengths exercise in particular and will use this in practice as part of the clinical supervision process.’
‘The process mapping and business case teaching was very useful…I will be using this straight away’
‘My most significant learning is knowing how to harness strengths and understanding my weaknesses - using this knowledge to my advantage.’
‘The most useful aspect for me was the expertise and feedback from the facilitators/coaches.’
Timelines
Submission deadline: Friday 13th September 2024
Notification of offer by: End of September 2024
Course start date: End of October 2024 – virtual welcome meeting
Online learning: October to January 2025
Face-to-face workshop: Mid-Feb 2025
To apply for a place, applicants need to submit this FORM to: ukons@media1productions.co.uk
*Please note that successful applicants are required to sign an agreement with Takeda for the transfer of value of each module to be declared on the ABPI Disclosure UK website*
The Takeda Oncology HCP professional development programme is developed for HCPs from the UK and is organised and funded by Takeda UK Limited.
The participants’ involvement in the programme is not related to any past, current or future Takeda commercial objectives nor will it be used as a means to encourage recipients to order, prescribe, or recommend Takeda products or to reward recipients for ordering, prescribing, or recommending Takeda products.